Brazil’s EMS seeking to acquire Teva’s Medis

The Brazilian daily O Estado de Sao Paolo has reported today that the local generics manufacturer EMS is targeting Teva’s division Medis, headquartered in Island, that produces generic drugs. EMS is already in talks with banks to obtain a $900m line of credit intended to fund the transaction, the author has reported. Analysts estimate that Teva has potential to earn a maximum $1bn by selling Medis.

(Source: O Estado de Sao Paolo)